HPS Pharmacies wish to advise that Southern XP is experiencing a supply interruption for Vasodrine® as follows:

Vasodrine® Tablets
Midodrine hydrochloride 2.5 mg
ARTG 309183 

Vasodrine® Tablets
Midodrine hydrochloride 5 mg
ARTG 309184

Normal supplies of Vasodrine® 2.5mg tablets are expected to resume by early-August 2023; Vasodrine® 5mg tablets are expected to return by end-September 2023.

An internationally registered alternative for the 2.5mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. This product is also currently experiencing supply issues in some states, although this is expected to resolve by end-May 2023.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Southern XP on (03) 7067 8510, or your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates